MEGGLE Excipients & Technology at Drug Delivery to the Lungs (DDL) 2019 in Edinburgh!
Pharmaceutical lactose specialist MEGGLE Excipients &Technology (MEGGLE) will attend the DDL Conference 2019 in Edinburg to present two new products suitable for use in pulmonary and nasal drug delivery.
MEGGLE Excipients & Technology rounds up the portfolio for dry powder inhalation with the new milled lactose grades InhaLac® 140 and InhaLac® 150. The two new inhalative lactose grades with specific particle size distributions are characterized by the typical flow- and surface-characteristic of milled lactose grades. This provides an additional tool for the formulator to tune and optimize the performance of the DPI product. As middle-sized milled carrier lactose, InhaLac 140 and InhaLac 150 are suitable for use in pulmonary and nasal drug delivery.
More information at DDL 2019 and https://www.meggle-pharma.com
Drop by at our booth 224 to learn more about our high functional excipients.
DDL 2019 – Opening hours
- December 11th 2019 – 11:00 – 18:00
- December 12th 2019 – 09:00 – 17:45
- December 13th 2019 – 09:00 – 13:00
DDL Conference 2019
The Exchange Edinburgh,
Further information on the conference venue:
Tickets – DDL 2019
Simply click here to buy your ticket via the official website!